Guidelines outline evaluation of children with global developmental delay

ST. PAUL, MN (February 4, 2003) Child neurologists with the American Academy of Neurology and the Child Neurology Society have released new practice guidelines recommending tests that should be used to diagnose even the youngest children with global developmental delay.

Between 40,000 and 120,000 U.S. and Canadian children are born each year with global developmental delay (mental retardation). While incurable, early testing and diagnosis of global developmental delay may help determine the cause of the disorder, and assist physicians and parents in developing a plan for treatment.

The guidelines are based on a review of all of the scientific studies on global developmental delay published from 1980 to 2000. The guidelines are published in the February 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

"Careful evaluation of the research showed that some of the newer tests, such as cytogenetic studies, should be used more often than they are, and others, such as routine metabolic screening, do not need to be used on every child with global developmental delay," said child neurologist Michael Shevell, MD, Montreal Children's Hospital, who is a co-author of the guidelines.

Among the guideline recommendations:

  • Routine cytogenetic studies and molecular testing for the Fragile X mutation
  • Serum lead level evaluations restricted to those with risk factors for excessive lead exposure
  • Electroencephalograms are not needed unless there is a history of seizures
  • Neuroimaging is recommended, especially if abnormalities are found on physical exam
  • Routine metabolic screening is not needed for the initial evaluation
  • Thyroid tests are not needed if the child had screening as a newborn, unless there are signs of thyroid dysfunction
  • Rett syndrome should be considered in girls with unexplained moderate to severe developmental delay

Shevell noted that

Contact: Cheryl Alementi
American Academy of Neurology

Page: 1 2

Related biology news :

1. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
2. New Guidelines To Improve Public Understanding
3. Guidelines For Next Generation Of Environmental Policy
4. Guidelines For Human Germ-Line Interventions Topic Of AAAS Forum
5. Genetic map of important tree genes outlined
6. Report outlines vision and recommendations for microbiology in the 21st Century
7. Report outlines steps needed to lessen smallpox threat
8. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
9. New research outlines public health consequences
10. Geoscience community outlines cooperative activities
11. The mechanics of anti-tumor activity outlined

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: